Filing Details

Accession Number:
0001209191-22-062643
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-23 17:03:07
Reporting Period:
2022-11-01
Accepted Time:
2022-12-23 17:03:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087294 Cumberland Pharmaceuticals Inc CPIX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1632384 C Joseph Galante 2525 West End Avenue
Suite 950
Nashville TN 37203
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-01 65 $2.53 54,506 No 4 P Direct
Common Stock Acquisiton 2022-11-02 65 $2.54 54,571 No 4 P Direct
Common Stock Acquisiton 2022-11-03 65 $2.44 54,636 No 4 P Direct
Common Stock Acquisiton 2022-11-04 65 $2.42 54,701 No 4 P Direct
Common Stock Acquisiton 2022-11-07 65 $2.45 54,766 No 4 P Direct
Common Stock Acquisiton 2022-11-08 65 $2.42 54,831 No 4 P Direct
Common Stock Acquisiton 2022-11-09 65 $2.37 54,896 No 4 P Direct
Common Stock Acquisiton 2022-11-10 65 $2.37 54,961 No 4 P Direct
Common Stock Acquisiton 2022-11-11 65 $2.32 55,026 No 4 P Direct
Common Stock Acquisiton 2022-11-14 65 $2.32 55,091 No 4 P Direct
Common Stock Acquisiton 2022-11-15 65 $2.35 55,156 No 4 P Direct
Common Stock Acquisiton 2022-11-16 65 $2.31 55,221 No 4 P Direct
Common Stock Acquisiton 2022-11-17 65 $2.29 55,286 No 4 P Direct
Common Stock Acquisiton 2022-11-18 65 $2.27 55,351 No 4 P Direct
Common Stock Acquisiton 2022-11-21 65 $2.38 55,416 No 4 P Direct
Common Stock Acquisiton 2022-11-22 65 $2.37 55,481 No 4 P Direct
Common Stock Acquisiton 2022-11-23 65 $2.29 55,546 No 4 P Direct
Common Stock Acquisiton 2022-11-25 65 $2.31 55,611 No 4 P Direct
Common Stock Acquisiton 2022-11-28 65 $2.37 55,676 No 4 P Direct
Common Stock Acquisiton 2022-11-29 65 $2.34 55,741 No 4 P Direct
Common Stock Acquisiton 2022-11-30 65 $2.32 55,806 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.